Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem/progenitor cells - Implication for the pathogenesis of immune thrombocytopenias

Folia Histochemica et Cytobiologica

Volumn 45, Issue 1, 2007, Pages 27-32

  Majka, Marcin ^a   Kijowski, Jacek ^a   Lesko, Ewa ^a   Goździk, Jolanta ^a   Zupanska, Barbara ^c   Ratajczak, Mariusz Z ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

ADCC; Endothelium; ITP; MV; Stem progenitor cells

Indexed keywords

HPA1A ANTIGEN; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; CD34 SELECTION; CELL SURFACE; CELL VACUOLE; CONTROLLED STUDY; CYTOPENIA; CYTOTOXICITY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOREACTIVITY; INCUBATION TIME; MONOCYTE; NATURAL KILLER CELL; PATHOGENESIS; PREGNANCY; THROMBOCYTE; UMBILICAL VEIN;

PAPAYA MOSAIC VIRUS;

EID: 33947194391     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod, 2004; 10: 55-63
2. Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res, 2003; 63: 5573-5581
3. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, Stringaro A, Molinari A, Arancia G, Gentile M, Parmiani G, Fais S. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med, 2002; 195: 1303-1316
4. Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol, 2002; 30: 450-459
5. Beaudoin AR, Grondin G. Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim Biophys Acta, 1991; 1071: 203-219
6. Bessos H, Goldschmeding R, von dem Borne A, Atkinson A, Murphy WG. The development of a simple and quick enzyme-linked immunosorbent assay for anti-HPA1a (PLA1) antibodies. Thromb Res, 1993; 69: 395-400
7. Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, Nugent DJ. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood, 2003; 102: 887-895
8. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med, 2002; 346: 995-1008
9. Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med, 2005; 56: 425-442
10. Fevrier B, Vilette D, Laude H, Raposo G. Exosomes: a bubble ride for prions? Traffic, 2005; 6: 10-17
11. Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR, Ratajczak J, Emerson SG, Kowalska MA, Ratajczak MZ. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood, 2001; 98: 3143-3149
12. Janowska-Wieczorek A, Marquez-Curtis L, Wysoczynski M, Ratajczak MZ. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion, 2006; 46: 1199-1209
13. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marques-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles Derived from Activated Platelets Induce Metastasis and Angiogenesis in Lung Cancer. Int J Cancer, 2005; 113: 752-760
14. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest, 1998; 102: 1393-1402
15. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol, 2002; 168: 3675-3682
16. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol, 2000; 37: 239-248
17. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood, 2004; 103: 1364-1369
18. McMillan R, Yelenosky RJ, Longmire RL. Antiplatelet antibody production by the spleen and bone marrow in immune thrombocytopenic purpura. In: JR Batisto, JW. Streinlein, eds. Immunoaspects of the Spleen, Amsterdam: North Holland Biomed, 1976; 227-237
19. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR. On behalf of the Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol, 2003; 122: 966-974
20. Pelchen-Matthews A, Raposo G, Marsh M. Endosomes, exosomes and Trojan viruses. Trends Microbiol, 2004; 12: 310-316
21. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia, 2006; 20: 847-856
22. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles (MV): importnat and underappreciated mediators of cell to cell communication. Leukemia, 2006; 20: 1487-1495
23. Rozmyslowicz T, Majka M, Kijowski J, Murphy SL, Conover DO, Poncz M, Ratajczak J, Gaulton GN, Ratajczak M. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS, 2003; 17: 33-42
24. Tarantino M. Recent advances in the treatment of childhood immune thrombocytopenic purpura. Semin Hematol, 2006; 43: S11-7; discussion S18-19